History and Aims

The European Society for the Study of Purine and Pyrimidine Metabolism in Man (ESSPPMM) was founded in 1987 in connection with the First European Symposium in Chateaux d’Oeux, Switzerland. Anne Simmonds. Francoise Roch-Ramel, Nepomuk Zöllner and Mathias Müller took the initiative. The Society held subsequent meetings every two years in several European countries.

Presidents of the European Society for the Study on Purine and Pyrimidine Metabolism in Man (ESSPPMM)

1987-1989

Francoise Roch-Ramel

Lausanne, Switzerland

1989-1991

Nepomuk Zöllner

München, Germany

1991-1993

H. Anne Simmonds

London, UK

1993-1995

Ronney A. de Abreu

Nijmegen, the Netherlands

1995-1997

Alessandro. Giacomello

Chieti, Italy

1997-1999

Mathias M. Müller

Vienna, Austria

1999-2001

W. Makarewicz

Gdansk, Poland

2001-2003

Georges H. van den Berghe

Brussels, Belgium

2003-2005

G.J. (Frits) Peters

Amsterdam, the Netherlands

2005-2007

Ivan Sebesta

Prague, Czech Republic

Presidents of the Purine and Pyrimidine Society

2007-2009

Michael A. Becker

Chicago, IL, USA

Richard L. Sabina

Milwaukee, WI, USA

2009-2011

Staffan Eriksson

Uppsala, Sweden

2011-2013

Staffan Eriksson

Uppsala, Sweden

Kimiyoshi Ichida

Tokyo, Japan

2013-2015

Juan G. Puig

Madrid, Spain

2015-2017

Michio Hirano

New York, NY, USA

2017-2019

R Tom Smolenski

Gdansk, Poland

2019-2021

Lars-Petter Jordheim

Lyon, France

The First International Symposium on Purine Metabolism was held in 1973 in Israel, and subsequently every three years in Europe, the USA, Israel and Japan. When the meetings coincided, a combined Symposium was held (in Bournemouth, UK, 1991; Gmunden, Austria, 1997; Egmond aan Zee, the Netherlands, 2003).

International and European Symposia on Purine and Pyrimidine Metabolism

Year

Venue

Organizer

1973

1st International Symposium on Purine Metabolism, Tel Aviv, Israel

A. De Vries

1976

2nd International Symposium on Purine Metabolism, Vienna, Austria.

M.M Müller

1979

3rd International Symposium on Purine Metabolism, Madrid, Spains

A. Rapado

1982

4th International Symposium on Purine and Pyrimidine Metabolism, Maastricht, the Netherlands

C.H.M.M. de Bruyn

1985

5th International Symposium on Purine and Pyrimidine Metabolism, San Diego, CA, USA

J.E. Seegmiller

1987

1st European Symposium on Purine and Pyrimidine Metabolism, Chateaux d’Oeux, Switzerland

F. Roch-Ramel

1988

6th International Symposium on Purine and Pyrimidine Metabolism, Hakone, Japan

K. Mikanagi

1989

2nd European Symposium on Purine and Pyrimidine Metabolism, Gut Ising, Germany

N. Zöllner

1991

7th International/3rd European Symposium on Purine and Pyrimidine Metabolism, Bournemouth, UK

H.A. Simmonds

1993

4th European Symposium on Purine and Pyrimidine Metabolism, Nijmegen, the Netherlands

R.A. de Abreu

1994

8th International Symposium on Purine and Pyrimidine Metabolism, Bloomington, IN, USA

M.W. Taylor

1995

5th European Symposium on Purine and Pyrimidine Metabolism, Termoli, Italy

A. Giacomello

1997

9th International/6th European Symposium on Purine and Pyrimidine Metabolism, Gmunden, Austria

M.M. Müller

1999

7th European Symposium on Purine and Pyrimidine Metabolism, Gdansk, Poland

W. Makarewicz

2000

10th International Symposium on Purine and Pyrimidine Metabolism, Tel Aviv, Israel

O. Sperling

2001

8th European Symposium on Purine and Pyrimidine Metabolism, Bruges, Belgium

G.H. van den Berghe

2003

11th International/9th European Symposium on Purine and Pyrimidine Metabolism, Egmond aan Zee, the Netherlands

G.J. Peters

2005

10th European Symposium on Purine and Pyrimidine Metabolism, Prague, Czech Republic

I. Sebesta

2007

12th International Symposium on Purine and Pyrimidine Metabolism, Chicago, IL, USA

M.A. Becker/

R.L. Sabina

2009

13th International Symposium on Purine and Pyrimidine Metabolism, Lidingo, Stockholm, Sweden

S. Eriksson

2011

14th International Symposium on Purine and Pyrimidine Metabolism, Tokyo, Japan

T. Hosoya

2013

15th International Symposium on Purine and Pyrimidine Metabolism in Man, Madrid, Spain

J.G. Puig

2015

16th International Symposium on Purine and Pyrimidine Metabolism in Man, New York, NY, USA

M. Hirano

2017

17th International Symposium on Purine and Pyrimidine Metabolism in Man, Gdansk, Poland

R.T. Smolenski

2019

18th International Symposium on Purine and Pyrimidine Metabolism in Man, Lyon, France

L.P. Jordheim

In 2003 the joint membership agreed to merge the activities of the two groups, which was approved by the General Assembly in 2005. In order to further strengthen the legal basis of the Purine and Pyrimidine Society, in 2008 the executive board decided to set up a foundation, which was approved in 2009 and established in 2010. The Purine and Pyrimidine Foundation, registered in the Netherlands is linked to the Society, and its board is appointed from that of the Purine and Pyrimidine Society.

In 2007 the first symposium in a new series of biennial Symposia was organized. The topics of the Symposia are determined by the participants who respond to the call for free communications, usually under broad headings such as:

Antimetabolites in the treatment of arthritis
Lesch-Nyhan syndrome
Gout
From bench to the clinic
Purines in the Cardiovascular system
Chemotherapy in solid and haematological malignancies
Thiopurines in therapy
Role of adenosine
Metabolism and enzymology
Enzymology: signal transduction
New inborn errors: role of mitochondria
Membrane targets
Antimetabolites: parasites and viruses
Genetic polymorphisms
Methodology
Gene therapy